Skip to content Skip to sidebar Skip to footer
mayne pharma
Mayne Pharma Collapses 30% as Treasurer Flags National-Interest Block in Cosette Deal
Mayne Pharma in Freefall: Regulatory Hurdle Threatens $672 m Buy-out Mayne Pharma (ASX: MYX) has suddenly become one of the most talked-about stocks on the ASX after the federal Treasurer raised serious national-interest concerns about its proposed takeover by Cosette Pharmaceuticals. The company that looked like it was on the cusp of being acquired is now…
curvebeam
CurveBeam AI Rockets 28% After China Deal Opens Door to 38,000 Hospitals
Could CurveBeam Be The Next 4DMedical CurveBeam AI’s share price jumped 28% today after the company released its quarterly update and announced a major partnership in China with Weiying Intelligent Medical Technology, a joint venture with Wego Orthopedics. This agreement marks a significant step forward in CurveBeam’s international expansion, opening the door to one of…
© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here